US Congress Senate Bill 801 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on March 14 2019 - 25% progression, died in committee
Action: 2019-03-14 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.

Sen. Catherine Cortez Masto [D-NV]

Sen. John Cornyn [R-TX]

Sen. Thomas Carper [D-DE]

Sen. Bill Cassidy [R-LA]

Date	Chamber	Action
2019-03-14	Senate	Read twice and referred to the Committee on Finance.

HB1264 (Related) 2019-02-15 - Referred to the Subcommittee on Health.
HB1781 (Related) 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/801/all-info
Text	https://www.congress.gov/116/bills/s801/BILLS-116s801is.pdf